| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7301614 | Neuroscience & Biobehavioral Reviews | 2018 | 69 Pages |
Abstract
Studies of cognitive impairment show salutary effects of acute administration of Ang IV and its analogs, as well as AT4R activation. Brain RAS peptides appear most effective administered intracerebroventricularly, close to the time of learning acquisition or retention testing. Ang-(1-7) shows anti-dementia qualities.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Jean K. Ho, Daniel A. Nation,